... investor relations, business development and human resource functions. Other general and administrative expenses include facility-related costs ...
The Investor Relations website contains information about Kinnate Biopharma's business for stockholders, potential investors, and financial analysts.
The Investor Relations website contains information about Merrimack Pharmaceuticals's business for stockholders, potential investors, and financial ...
CNS Pharmaceuticals a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic ...
Investor Relations. Fusion Pharmaceuticals is a ... cancer. We have developed our Targeted Alpha ... We believe this evolution of radiopharmaceuticals holds great ...
April 11, 2024. Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes · April 8, 2024 · April 8, 2024 · April 4, ...
Concert Pharmaceuticals (CNCE) Investor Presentation - Slideshow · SA TranscriptsMon, May 17, 2021. Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q1 ...
Missing: relations | Show results with:relations
The Investor Relations website contains information about C4 Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
Investor Relations ; $66.42. NASDAQ: NUVL ; $0.91 (1.39%). Change ; 149.2K · Volume ; $4.3B · Market Cap.
Corporate Profile for Repare Therapeutics, a clinical-stage precision oncology company discovering and developing novel, synthetic lethal medicines.
